IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes

PLoS One. 2013 Nov 18;8(11):e79445. doi: 10.1371/journal.pone.0079445. eCollection 2013.

Abstract

Trypanosoma cruzi (T. cruzi) infection produces an intense inflammatory response which is critical for the control of the evolution of Chagas' disease. Interleukin (IL)-10 is one of the most important anti-inflammatory cytokines identified as modulator of the inflammatory reaction. This work shows that exogenous addition of IL-10 inhibited ERK1/2 and NF-κB activation and reduced inducible nitric oxide synthase (NOS2), metalloprotease (MMP) -9 and MMP-2 expression and activities, as well as tumour necrosis factor (TNF)-α and interleukin (IL)-6 expression, in T. cruzi-infected cardiomyocytes. We found that T. cruzi and IL-10 promote STAT3 phosphorylation and up-regulate the expression of suppressor of cytokine signalling (SOCS)-3 thereby preventing NF-κB nuclear translocation and ERK1/2 phosphorylation. Specific knockdown of SOCS-3 by small interfering RNA (siRNA) impeded the IL-10-mediated inhibition of NF-κB and ERK1/2 activation. As a result, the levels of studied pro-inflammatory mediators were restored in infected cardiomyocytes. Our study reports the first evidence that T. cruzi up- regulates SOCS-3 expression and highlights the relevance of IL-10 in the modulation of pro-inflammatory response of cardiomyocytes in Chagas' disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Interleukin-10 / pharmacology*
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / parasitology*
  • NF-kappa B / metabolism*
  • Phosphorylation / drug effects
  • Suppressor of Cytokine Signaling Proteins / metabolism*
  • Trypanosoma cruzi / pathogenicity*

Substances

  • NF-kappa B
  • Suppressor of Cytokine Signaling Proteins
  • Interleukin-10
  • Mitogen-Activated Protein Kinase 1

Grants and funding

This work was supported by Grants PICT 2007 N° 995 from Agencia Nacional de Promoción de Ciencia y Tecnología (ANPCyT) Argentina and PIP 1424 from Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Argentina and UBACyT 20020100100809 from Universidad de Buenos Aires, Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.